Iksuda Therapeutics

Newcastle Upon Tyne, United Kingdom

Drug DeliveryProprietary Research & Manufacture Basic Listing
C-Score
35%
Developing Profile
Company Details
Address The Biosphere Draymans Way, Newcastle Helix, Newcastle upon Tyne, NE4 5BX
Country United Kingdom
Sectors Drug Delivery, Proprietary Research & Manufacture
Website Visit Website
Company Activities

Our ADCs target difficult-to-treat cancers, including those that are resistant or refractory to current therapies.

Through our highly experienced ADC Development Team, we are building a pipeline of best in class ADCs with superior therapeutic index (TI).

Our approach is to develop the best ADCs for each tumour or tumour sub-type through careful selection of the right combinations of payload, linker and conjugation chemistry.

Iksuda has built a portfolio of ADC assets including;

  • PermaLink® – our proprietary conjugation chemistry for improved ADC stability
  • Novel payloads with a variety of mechanisms for improved tumour killing, including pro-drug approaches for added safety
  • Novel antibodies towards targeted well-selected antigens associated primarily with solid tumours
Sectors
Drug Delivery
Proprietary Research & Manufacture
Category/Key Word(s)
Biologics
Biotechnology
Drug Conjugates & Linkers
Antibodies-monoclonals
Antibody Drug Conjugates
Clinical Development-Pipeline
Bioconjugation
Tumour Targeting
Company Contacts

No key contacts have been added to this profile yet.

Company Reviews

No reviews have been added to this profile yet.

Claim This Profile

This is the company profile page for Iksuda Therapeutics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

Company Pages
Overview Partnerships News Financials Media Priority Listing Advertise Locations Statistics Blogs